The founder of the New England Compounding Center and one of its supervising pharmacists couldn’t convince the First Circuit on Thursday to overturn their convictions or prison sentences related to a 2012 fungal meningitis outbreak.
The U.S. Court of Appeals for the First Circuit instead vacated and remanded their sentences and forfeiture orders for reconsideration.
The meningitis outbreak was traced back to medications produced at NECC, which had represented to its customers that its facilities were in full compliance with safety standards. Founder Barry Cadden and pharmacist Glenn Chin were charged with more than 100 federal crimes, including racketeering, racketeering ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.